如何应对抗疟药物耐药性？
How to tackle antimalarial resistance?
机构信息
Medicines for Malaria Venture, Geneva, Switzerland.
出版信息
EMBO Mol Med. 2017 Feb;9(2):133-134. doi: 10.15252/emmm.201607295.
Abstract
In the context of drug resistance, malaria is no exception. Even the latest artemisinins have started to lose their full efficacy in patients. Didier Leroy tells us about the strategies adopted by Medicines for Malaria Venture to reduce this terrible culprit. [Image: see text]
摘要
在耐药性方面，疟疾也不例外。即使是最新的青蒿素类药物，也开始在患者身上失去全部疗效。Didier Leroy 向我们介绍了疟疾药物开发联盟采取的策略，以减少这一可怕的罪魁祸首。[图片：见正文]
相似文献
1
How to tackle antimalarial resistance?
EMBO Mol Med. 2017 Feb;9(2):133-134. doi: 10.15252/emmm.201607295.
2
Drug-resistant malaria advances in Mekong.
Science. 2017 Oct 13;358(6360):155-156. doi: 10.1126/science.358.6360.155.
3
Evidence of Artemisinin-Resistant Plasmodium falciparum Malaria in Eastern India.
N Engl J Med. 2018 Nov 15;379(20):1962-1964. doi: 10.1056/NEJMc1713777.
4
Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.
Lancet Infect Dis. 2015 Jun;15(6):683-91. doi: 10.1016/S1473-3099(15)70049-6. Epub 2015 Apr 12.
5
Spread of a single multidrug resistant malaria parasite lineage (PfPailin) to Vietnam.
Lancet Infect Dis. 2017 Oct;17(10):1022-1023. doi: 10.1016/S1473-3099(17)30524-8.
6
Emergence of Indigenous Artemisinin-Resistant Plasmodium falciparum in Africa.
N Engl J Med. 2017 Mar 9;376(10):991-3. doi: 10.1056/NEJMc1612765. Epub 2017 Feb 22.
7
Back on TRAC: New trial launched in bid to outpace multidrug-resistant malaria.
Nat Med. 2016 Mar;22(3):220-1. doi: 10.1038/nm0316-220.
8
High Antimalarial Efficacy of Dihydroartemisinin-Piperaquine on the China-Myanmar Border: The Calm Before the Storm.
Am J Trop Med Hyg. 2015 Sep;93(3):436-437. doi: 10.4269/ajtmh.15-0349. Epub 2015 Aug 17.
9
A brief history of artemisinin: Modes of action and mechanisms of resistance.
Chin J Nat Med. 2019 May 20;17(5):331-336. doi: 10.1016/S1875-5364(19)30038-X.
10
Skirmishing over the scope of the threat.
Science. 2016 Apr 22;352(6284):403. doi: 10.1126/science.352.6284.403. Epub 2016 Apr 21.
引用本文的文献
1
Grasp of dihydroartemisinin resistance in Indonesia: Focused on genetic polymorphisms and new antimalarial.
Narra J. 2023 Dec;3(3):e336. doi: 10.52225/narra.v3i3.336. Epub 2023 Dec 11.
2
Susceptibility of Ugandan Plasmodium falciparum Isolates to the Antimalarial Drug Pipeline.
Microbiol Spectr. 2023 Jun 15;11(3):e0523622. doi: 10.1128/spectrum.05236-22. Epub 2023 May 9.
3
Dual-pharmacophore artezomibs hijack the Plasmodium ubiquitin-proteasome system to kill malaria parasites while overcoming drug resistance.
Cell Chem Biol. 2023 May 18;30(5):457-469.e11. doi: 10.1016/j.chembiol.2023.04.006. Epub 2023 May 5.
4
Assessing risks of Plasmodium falciparum resistance to select next-generation antimalarials.
Trends Parasitol. 2021 Aug;37(8):709-721. doi: 10.1016/j.pt.2021.04.006. Epub 2021 May 14.
5
MalDA, Accelerating Malaria Drug Discovery.
Trends Parasitol. 2021 Jun;37(6):493-507. doi: 10.1016/j.pt.2021.01.009. Epub 2021 Feb 26.
6
Amodiaquine resistance in is associated with His95Pro mutation, loss of chloroquine, artemisinin and primaquine sensitivity, and high transcript levels of key transporters.
Wellcome Open Res. 2017 Jun 20;2:44. doi: 10.12688/wellcomeopenres.11768.2. eCollection 2017.
7
Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic.
Nat Med. 2017 Aug 4;23(8):917-928. doi: 10.1038/nm.4381.
8
K13 Mutations Differentially Impact Ozonide Susceptibility and Parasite Fitness .
mBio. 2017 Apr 11;8(2):e00172-17. doi: 10.1128/mBio.00172-17.
本文引用的文献
1
A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study.
Lancet Infect Dis. 2017 Feb;17(2):174-183. doi: 10.1016/S1473-3099(16)30415-7. Epub 2016 Nov 3.
2
Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study.
Lancet Infect Dis. 2017 Feb;17(2):164-173. doi: 10.1016/S1473-3099(16)30409-1. Epub 2016 Nov 3.
3
Artemisinin Action and Resistance in Plasmodium falciparum.
Trends Parasitol. 2016 Sep;32(9):682-696. doi: 10.1016/j.pt.2016.05.010. Epub 2016 Jun 9.
4
Identification of a Non-Gatekeeper Hot Spot for Drug-Resistant Mutations in mTOR Kinase.
Cell Rep. 2015 Apr 21;11(3):446-59. doi: 10.1016/j.celrep.2015.03.040. Epub 2015 Apr 9.
5
The effects of chromatin organization on variation in mutation rates in the genome.
Nat Rev Genet. 2015 Apr;16(4):213-23. doi: 10.1038/nrg3890. Epub 2015 Mar 3.
6
Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
Infect Disord Drug Targets. 2013 Aug;13(4):217-77. doi: 10.2174/1871526513666131129155708.
7
Artemisinin resistance in Plasmodium falciparum malaria.
N Engl J Med. 2009 Jul 30;361(5):455-67. doi: 10.1056/NEJMoa0808859.
Zotero 插件